Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism UHRF1 antagonists(ubiquitin like with PHD and ring finger domains 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myeloid Leukemia | Preclinical | CN | 27 Oct 2022 |